Workiva AI vs Aidoc AI

Enterprise licensing. No public pricing. Annual contracts. Publicly traded (WK). Demo available.

Enterprise licensing to health systems and radiology groups. No public pricing. FDA-cleared for multiple indications. Contact for pricing.

Financial and ESG disclosure data processed on Workiva's infrastructure under enterprise data handling agreements with financial services security standards.

Medical image and clinical data processed under HIPAA BAA and applicable healthcare privacy regulations. FDA-cleared for specific clinical indications — review clearance scope for each deployment.

• ✓Most Fortune 500 public companies use Workiva — unmatched validation for financial and ESG reporting
• ✓AI consistency checking catches cross-reference errors that create SEC comment letters
• ✓ESG reporting framework alignment (GRI, SASB, TCFD, CSRD) covers major global sustainability disclosure requirements
• ✓Data connectivity eliminates manual data entry reducing error risk in filings

• ✓Broadest portfolio of FDA-cleared radiology AI algorithms — regulatory clearance required for clinical deployment
• ✓Worklist prioritisation for time-critical conditions (stroke, PE) has direct patient outcome impact
• ✓aiOS platform enables health systems to manage multiple AI algorithms through one integration
• ✓Published clinical evidence from real-world deployments validates outcomes claims

• ✕Enterprise-only pricing — appropriate for public companies with formal reporting obligations
• ✕Implementation and adoption requires significant finance team change management
• ✕Not relevant for private companies without regulatory reporting obligations

• ✕Enterprise health system sales cycles are long and require IT, clinical, and procurement alignment
• ✕FDA clearance is indication-specific — algorithms not cleared for a specific indication cannot be deployed clinically
• ✕Integration with existing PACS and RIS systems requires significant IT implementation effort